US6531478B2
(en)
|
2000-02-24 |
2003-03-11 |
Cheryl P. Kordik |
Amino pyrazole derivatives useful for the treatment of obesity and other disorders
|
GB0010757D0
(en)
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
AU2002221222A1
(en)
*
|
2000-12-04 |
2002-06-18 |
Biovitrum Ab |
Novel method and use
|
SE0004462D0
(sv)
*
|
2000-12-04 |
2000-12-04 |
Pharmacia Ab |
Novel method and use
|
GB0121941D0
(en)
|
2001-09-11 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
GT200200188A
(es)
*
|
2001-09-24 |
2003-06-25 |
|
Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad
|
DE60208815T2
(de)
*
|
2001-10-12 |
2006-07-20 |
Bayer Pharmaceuticals Corp., West Haven |
Phenyl substituierte 5-gliedrige stickstoff enthaltende heterocyclen zur behandlung von fettleibigkeit
|
ES2316777T3
(es)
|
2002-02-15 |
2009-04-16 |
Glaxo Group Limited |
Moduladores de receptores vainilloides.
|
US7074805B2
(en)
*
|
2002-02-20 |
2006-07-11 |
Abbott Laboratories |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
MXPA05000200A
(es)
|
2002-07-02 |
2005-06-06 |
Schering Corp |
Nuevos antagonistas del receptor neuropeptido y y5.
|
US7429581B2
(en)
|
2002-12-23 |
2008-09-30 |
Sanofi-Aventis Deutschland Gmbh |
Pyrazole-derivatives as factor Xa inhibitors
|
EP1433788A1
(de)
*
|
2002-12-23 |
2004-06-30 |
Aventis Pharma Deutschland GmbH |
Pyrazol-Derivate als Faktor Xa Inhibitoren
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US6933311B2
(en)
*
|
2003-02-11 |
2005-08-23 |
Abbott Laboratories |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
|
US7531558B2
(en)
|
2003-02-14 |
2009-05-12 |
Glaxo Group Limited |
Carboxamide derivatives
|
US20040220170A1
(en)
*
|
2003-05-01 |
2004-11-04 |
Atkinson Robert N. |
Pyrazole-amides and sulfonamides as sodium channel modulators
|
JP2006525355A
(ja)
*
|
2003-05-01 |
2006-11-09 |
アボット・ラボラトリーズ |
ナトリウムチャンネルモジュレーターとしてのピラゾール−アミドおよびスルホンアミド
|
WO2004108133A2
(en)
*
|
2003-06-05 |
2004-12-16 |
Vertex Pharmaceuticals Incorporated |
Modulators of vr1 receptor
|
US7015233B2
(en)
*
|
2003-06-12 |
2006-03-21 |
Abbott Laboratories |
Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
|
US20070032537A1
(en)
*
|
2003-06-13 |
2007-02-08 |
Arena Pharmaceuticals, Inc. |
5-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseases
|
US20050113576A1
(en)
*
|
2003-08-05 |
2005-05-26 |
Chih-Hung Lee |
Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
|
US7547693B2
(en)
|
2003-09-22 |
2009-06-16 |
Banyu Pharmaceutical Co. Ltd. |
Piperidine derivative
|
TW200533657A
(en)
*
|
2004-02-17 |
2005-10-16 |
Esteve Labor Dr |
Substituted pyrazoline compounds, their preparation and use as medicaments
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
WO2006032851A1
(en)
*
|
2004-09-20 |
2006-03-30 |
Biolipox Ab |
Pyrazole compounds useful in the treatment of inflammation
|
EP2286840A3
(de)
|
2004-11-01 |
2013-09-04 |
Amylin Pharmaceuticals, LLC |
Behandlung von Fettleibigkeit und von verwandten Krankheiten
|
US20090286723A1
(en)
|
2005-02-11 |
2009-11-19 |
Amylin Pharmaceuticals, Inc. |
Hybrid Polypeptides with Selectable Properties
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
WO2006094236A1
(en)
*
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
N-phenyl benzamide derivatives as sirtuin modulators
|
EP1885369B1
(de)
|
2005-05-04 |
2015-09-23 |
Evotec AG |
Fusionierte heterozyklische verbindungen und zusammensetzungen sowie anwendungen davon
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
US8138206B2
(en)
|
2005-05-30 |
2012-03-20 |
Msd. K.K. |
Piperidine derivative
|
US7923465B2
(en)
|
2005-06-02 |
2011-04-12 |
Glenmark Pharmaceuticals S.A. |
Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
|
EP1757587A1
(de)
*
|
2005-07-15 |
2007-02-28 |
Laboratorios Del Dr. Esteve, S.A. |
Substituierte Pyrazolinderivate, ihre Herstellung und Verwendung als Arzneimittel
|
EP1743892A1
(de)
*
|
2005-07-15 |
2007-01-17 |
Laboratorios del Dr. Esteve S.A. |
Substituierte Pyrazolin Verbindungen, deren Herstellung und Verwendung als Medikament
|
US7897589B2
(en)
*
|
2005-07-15 |
2011-03-01 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted pyrazoline compounds, their preparation and use as medicaments
|
EP1743890A1
(de)
|
2005-07-15 |
2007-01-17 |
Laboratorios Del Dr. Esteve, S.A. |
4,5-Dihydro-1H-Pyrazol-Derivative, Verfahren zur Herstellung und ihre Verwendung als Medikamente.
|
US8088928B2
(en)
|
2005-08-04 |
2012-01-03 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
WO2007019417A1
(en)
|
2005-08-04 |
2007-02-15 |
Sirtris Pharmaceuticals, Inc. |
Oxazolopyridine derivatives as sirtuin modulators
|
US8093401B2
(en)
*
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
US7855289B2
(en)
|
2005-08-04 |
2010-12-21 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
WO2007018248A1
(ja)
|
2005-08-10 |
2007-02-15 |
Banyu Pharmaceutical Co., Ltd. |
ピリドン化合物
|
BRPI0614649A2
(pt)
|
2005-08-11 |
2011-04-12 |
Amylin Pharmaceuticals Inc |
polipeptìdeos hìbridos com propriedades selecionáveis
|
WO2007024004A1
(ja)
|
2005-08-24 |
2007-03-01 |
Banyu Pharmaceutical Co., Ltd. |
フェニルピリドン誘導体
|
JPWO2007029847A1
(ja)
|
2005-09-07 |
2009-03-19 |
萬有製薬株式会社 |
二環性芳香族置換ピリドン誘導体
|
KR20080048502A
(ko)
|
2005-09-29 |
2008-06-02 |
머크 앤드 캄파니 인코포레이티드 |
멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
|
TW200800911A
(en)
*
|
2005-10-20 |
2008-01-01 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
WO2007048027A2
(en)
|
2005-10-21 |
2007-04-26 |
Novartis Ag |
Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
|
US8163770B2
(en)
|
2005-10-27 |
2012-04-24 |
Msd. K. K. |
Benzoxathiin derivative
|
TW200732320A
(en)
*
|
2005-10-31 |
2007-09-01 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
WO2007051982A1
(en)
*
|
2005-10-31 |
2007-05-10 |
Biolipox Ab |
Triazole compounds as lipoxygenase inhibitors
|
WO2007052000A1
(en)
*
|
2005-11-01 |
2007-05-10 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
WO2007055418A1
(ja)
|
2005-11-10 |
2007-05-18 |
Banyu Pharmaceutical Co., Ltd. |
アザ置換スピロ誘導体
|
EP2046787B1
(de)
|
2006-08-01 |
2011-04-06 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridinverbindungen und ihre verwendung als pde4-inhibitoren
|
TW200824687A
(en)
*
|
2006-08-25 |
2008-06-16 |
Abbott Lab |
Compounds that inhibit TRPV1 and uses thereof
|
WO2008039327A2
(en)
|
2006-09-22 |
2008-04-03 |
Merck & Co., Inc. |
Method of treatment using fatty acid synthesis inhibitors
|
AU2007301126A1
(en)
|
2006-09-28 |
2008-04-03 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
EP2134678A2
(de)
*
|
2006-12-20 |
2009-12-23 |
Abbott Laboratories |
N-(5,6,7,8-tetrahydronaphthalin-1-yl)harnstoffderivate und verwandte verbindungen als antagonisten des trpv1-vanilloidrezeptors zur behandlung von schmerzen
|
JP5319518B2
(ja)
|
2007-04-02 |
2013-10-16 |
Msd株式会社 |
インドールジオン誘導体
|
WO2008123963A1
(en)
|
2007-04-02 |
2008-10-16 |
Renovis, Inc. |
Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
|
US8076345B2
(en)
|
2007-04-17 |
2011-12-13 |
Evotec Ag |
2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
|
ES2393885T7
(es)
|
2007-06-04 |
2014-01-30 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
TW200916472A
(en)
|
2007-06-20 |
2009-04-16 |
Sirtris Pharmaceuticals Inc |
Sirtuin modulating compounds
|
UA105758C2
(uk)
|
2007-07-19 |
2014-06-25 |
Х. Луннбек А/С |
5-членні гетероциклічні аміди та споріднені сполуки
|
JP2010534722A
(ja)
*
|
2007-07-27 |
2010-11-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
新規グルコキナーゼ活性化薬およびその使用方法
|
CA2704336A1
(en)
*
|
2007-11-01 |
2009-05-07 |
Sirtris Pharmaceuticals, Inc. |
Amide derivatives as sirtuin modulators
|
US20110009381A1
(en)
*
|
2007-11-08 |
2011-01-13 |
Sirtis Pharmaceuticals, Inc. |
Solubilized thiazolopyridines
|
CN101981003B
(zh)
|
2008-02-29 |
2014-07-02 |
伊沃泰克股份公司 |
酰胺化合物、组合物及其应用
|
JPWO2009110510A1
(ja)
|
2008-03-06 |
2011-07-14 |
Msd株式会社 |
アルキルアミノピリジン誘導体
|
CA2719018A1
(en)
*
|
2008-03-20 |
2009-09-24 |
Abbott Laboratories |
Methods for making central nervous system agents that are trpv1 antagonists
|
CN101981025A
(zh)
|
2008-03-28 |
2011-02-23 |
万有制药株式会社 |
具有黑色素浓缩激素受体拮抗作用的二芳基甲基酰胺衍生物
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
AU2009270833B2
(en)
|
2008-07-16 |
2015-02-19 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
EP2151234A1
(de)
*
|
2008-07-28 |
2010-02-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Pharmazeutische Formulierung mit einer CB1-Rezeptorverbindung in einer festen Lösung und/oder festen Dispersion
|
WO2010013595A1
(ja)
|
2008-07-30 |
2010-02-04 |
萬有製薬株式会社 |
5員-5員又は5員-6員縮環シクロアルキルアミン誘導体
|
MX2011004258A
(es)
|
2008-10-22 |
2011-06-01 |
Merck Sharp & Dohme |
Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos.
|
BRPI0919876A8
(pt)
|
2008-10-30 |
2016-02-10 |
Merck Sharp & Dohme |
Composto, composição farmacêutica, uso de um composto, e, método para intensificar a qualidade do sono, para tratar insônia, e para tratar ou controlar obesidade em um paciente mamífero que necessita do mesmo.
|
CA2741672A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
US20110243940A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Bicyclic pyranone derivatives and methods of use thereof
|
EP2379547A1
(de)
|
2008-12-16 |
2011-10-26 |
Schering Corporation |
Pyridopyrimidinderivate und verfahren zu deren anwendung
|
EA021424B1
(ru)
|
2008-12-19 |
2015-06-30 |
Сертрис Фармасьютикалз, Инк. |
Тиазолопиридиновые соединения, регулирующие сиртуин
|
US8946231B2
(en)
|
2009-03-23 |
2015-02-03 |
Merck Sharp & Dohme Corp. |
P2X3, receptor antagonists for treatment of pain
|
US9452980B2
(en)
|
2009-12-22 |
2016-09-27 |
Hoffmann-La Roche Inc. |
Substituted benzamides
|
CA2786314A1
(en)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
KR101668514B1
(ko)
|
2011-02-25 |
2016-10-21 |
머크 샤프 앤드 돔 코포레이션 |
항당뇨병제로서 유용한 신규 시클릭 아자벤즈이미다졸 유도체
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
JP2015525782A
(ja)
|
2012-08-02 |
2015-09-07 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
抗糖尿病性三環式化合物
|
RU2015140066A
(ru)
|
2013-02-22 |
2017-03-30 |
Мерк Шарп И Доум Корп. |
Противодиабетические бициклические соединения
|
US9650375B2
(en)
|
2013-03-14 |
2017-05-16 |
Merck Sharp & Dohme Corp. |
Indole derivatives useful as anti-diabetic agents
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
US10011637B2
(en)
|
2013-06-05 |
2018-07-03 |
Synergy Pharmaceuticals, Inc. |
Ultra-pure agonists of guanylate cyclase C, method of making and using same
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
MX2017002610A
(es)
|
2014-08-29 |
2017-10-11 |
Tes Pharma S R L |
INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA.
|
WO2017059191A1
(en)
|
2015-09-30 |
2017-04-06 |
Quartet Medicine, Inc. |
Heteroaryl derivatives as sepiapterin reductase inhibitors
|
RU2731095C2
(ru)
|
2016-03-17 |
2020-08-28 |
Ф. Хоффманн-Ля Рош Аг |
Производное 5-этил-4-метил-пиразол-3-карбоксамида, обладающее активностью агониста taar
|
US20180134667A1
(en)
|
2016-10-14 |
2018-05-17 |
TES Pharma S.r.I. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
WO2018106518A1
(en)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
US10968232B2
(en)
|
2016-12-20 |
2021-04-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
MX2021005904A
(es)
|
2018-11-20 |
2021-09-08 |
Tes Pharma S R L |
Inhibidores de la ácido alfa-amino-beta-carboximucónico semialdehído descarboxilasa.
|
WO2020167706A1
(en)
|
2019-02-13 |
2020-08-20 |
Merck Sharp & Dohme Corp. |
5-alkyl pyrrolidine orexin receptor agonists
|
WO2021026047A1
(en)
|
2019-08-08 |
2021-02-11 |
Merck Sharp & Dohme Corp. |
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
|
EP4017850A1
(de)
*
|
2019-08-21 |
2022-06-29 |
Kalvista Pharmaceuticals Limited |
Enzymhemmer
|
WO2021046515A1
(en)
*
|
2019-09-06 |
2021-03-11 |
Board Of Regents, The University Of Texas System |
Inhibitors of receptor interacting protein kinase i for the treatment of disease
|
US11753381B2
(en)
|
2019-09-27 |
2023-09-12 |
Board Of Regents, The University Of Texas System |
Inhibitors of receptor interacting protein kinase I for the treatment of disease
|
CN114981248A
(zh)
|
2019-11-26 |
2022-08-30 |
德州大学系统董事会 |
用于治疗疾病的受体相互作用蛋白激酶i的抑制剂
|
US20230365533A1
(en)
|
2020-08-18 |
2023-11-16 |
Merck Sharp & Dohme Llc |
Bicycloheptane pyrrolidine orexin receptor agonists
|